Researchers from the Icahn School of Medicine at Mount Sinai have discovered a molecular switch in neurons that limits the regrowth of damaged axonal...

THURSDAY, April 2, 2026 -- Glucagon-like peptide-1 (GLP-1) receptor agonist (RA) use is associated with delayed wound healing in patients undergoing...

THURSDAY, April 2, 2026 -- Glucagon-like peptide-1 (GLP-1) receptor agonist (RA) use is associated with delayed wound healing in patients undergoing...

The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over...

The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over...

UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo NordiskIn...

Living with diabetes often means dealing with daily insulin injections. For many people, this routine is not only uncomfortable but also emotionally...

The results suggest that the five-year risk of major cardiovascular events such as heart attacks and the risk of end-stage kidney disease were reduced...

MONDAY, March 23, 2026 -- Periconceptional exposure to glucagon-like peptide-1 (GLP-1) receptor agonists is associated with increased odds of preterm...

Eli Lilly stock gains on FDA nod for oral obesity drug Foundayo, expanding its portfolio and patient access, setting up a fresh showdown with Novo...